These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8524985)

  • 21. Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs.
    Kuoppamäki M; Pälvimäki EP; Hietala J; Syvälahti E
    Neuropsychopharmacology; 1995 Oct; 13(2):139-50. PubMed ID: 8597525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats.
    Chaki S; Funakoshi T; Yoshikawa R; Okuyama S; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
    Neuropharmacology; 1999 Aug; 38(8):1185-94. PubMed ID: 10462131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
    Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats.
    Porter JH; Varvel SA; Vann RE; Philibin SD; Wise LE
    Psychopharmacology (Berl); 2000 Apr; 149(2):189-93. PubMed ID: 10805615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of serotonin in the action of atypical antipsychotic drugs.
    Meltzer HY
    Clin Neurosci; 1995; 3(2):64-75. PubMed ID: 7583621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
    Reuss B; Unsicker K
    Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptor pharmacology.
    Seeman P; Van Tol HH
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic.
    Funakoshi T; Chaki S; Kawashima N; Suzuki Y; Yoshikawa R; Kumagai T; Nakazato A; Kameo K; Goto M; Okuyama S
    Life Sci; 2002 Aug; 71(12):1371-84. PubMed ID: 12127158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs.
    Tarazi FI; Yeghiayan SK; Neumeyer JL; Baldessarini RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):693-707. PubMed ID: 9682281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].
    Futamura T; Ohashi Y; Yano K; Takahashi Y; Haga K; Fukuda T
    Nihon Yakurigaku Zasshi; 1996 May; 107(5):247-53. PubMed ID: 8690306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile.
    Needham PL; Atkinson J; Skill MJ; Heal DJ
    Psychopharmacol Bull; 1996; 32(1):123-8. PubMed ID: 8927661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo.
    Di Matteo V; Cacchio M; Di Giulio C; Di Giovanni G; Esposito E
    Pharmacol Biochem Behav; 2002 Apr; 71(4):607-13. PubMed ID: 11888552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
    Oerther S; Ahlenius S
    J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action.
    Cohen BM; Lipinski JF
    Life Sci; 1986 Dec; 39(26):2571-80. PubMed ID: 2879204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.
    Bubeníková V; Votava M; Horácek J; Pálenícek T; Dockery C
    Pharmacol Biochem Behav; 2005 Apr; 80(4):591-6. PubMed ID: 15820528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into the biology of schizophrenia through the mechanism of action of clozapine.
    Brunello N; Masotto C; Steardo L; Markstein R; Racagni G
    Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction: What makes an antipsychotic atypical?
    Stahl SM
    J Clin Psychiatry; 1999; 60 Suppl 10():3-4. PubMed ID: 10340681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.